e-learning
resources
European Respiratory Review
2013
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chronic post-embolic pulmonary hypertension: a new target for medical therapies?},
Marion Delcroix
Source:
Eur Respir Rev 2013; 22: 258-264
Journal Issue:
September 2013 - 22 (129)
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marion Delcroix. Chronic post-embolic pulmonary hypertension: a new target for medical therapies?},. Eur Respir Rev 2013; 22: 258-264
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Chronic thromboembolic pulmonary hypertension: do we need a new definition?
Source: Eur Respir J 2014; 44: 1401-1403
Year: 2014
Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ?
Source: International Congress 2018 – French Programme 2018: Part II
Year: 2018
Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow?},
Source: Eur Respir Rev 2013; 22: 217-226
Year: 2013
Emerging anti-inflammatory strategies for COPD},
Source: Eur Respir J 2012; 40: 724-741
Year: 2012
Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options
Source: Eur Respir Rev 2009; 18: 24-28
Year: 2009
Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future},
Source: Eur Respir Rev 2013; 22: 281-291
Year: 2013
Different treatment modalities in chronic thromboembolic pulmonary hypertension: how to combine them?
Source: International Congress 2017 – Open questions in pulmonary vascular diseases
Year: 2017
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era},
Source: Eur Respir J 2012; 40: 881-885
Year: 2012
The effectiveness of anti-inflammatory therapy for chronic obstructive pulmonary disease complicated by ischemic heart disease (new medication - new opportunities)
Source: International Congress 2014 – Comorbidities
Year: 2014
Learning to pair therapies and the expanding matrix for pulmonary arterial hypertension: is more better?
Source: Eur Respir J 2006 Oct 01;28(4):683-686
Year: 2006
Treatment of pulmonary hypertension due to COPD: can we really hope in better?
Source: Eur Respir J 2005; 26: Suppl. 49, 562s
Year: 2005
Drug-induced pulmonary arterial hypertension: a recent outbreak},
Source: Eur Respir Rev 2013; 22: 244-250
Year: 2013
Chronic thromboembolic pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 108-118
Year: 2012
Update on current treatment options of pulmonary hypertension
Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine
Year: 2006
Interventional treatment of pulmonary hypertension: where are we now?
Source: Virtual Congress 2020 – Breathing disorders and cardiovascular diseases
Year: 2020
Combination therapy for chronic obstructive pulmonary disease: one size fits all?
Source: Eur Respir J 2003 Dec 01;22(6):874-875
Year: 2003
Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready?
Source: Eur Respir J 2014; 44: 1404-1407
Year: 2014
Antithrombotics in pulmonary hypertension: more work needed before we turn to newer agents!
Source: Eur Respir J 2013; 41: 775-777
Year: 2013
Pulmonary hypertension: new guidelines for therapy
Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept